Johnson & Johnson to Host Investor Conference Call on Second-Quarter R...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 25, 2024

NetEase, Inc. Announces Filing of Annual Report on Form 20-F for Fiscal Year 2023 and Publication of 2023 Environmental, Social • Essential Utilities Donated $5.5 Million in 2023 to Strengthen Communities Across Service Territory • Puyallup Tribal Enterprises Becomes Lead Investor in Skip Technology • ACTS LAW Addresses Federal Correctional Institution in Dublin Controversy • Bureau Veritas: Strong Start to the Year; 2024 Outlook Confirmed • ISC2 Research Finds Some Progress, But More Needs to be Done to Support Women in Cybersecurity • Congruent Solutions Appoints Mahesh Natarajan as Chief Revenue Officer • Motlow State Community College Expands Accessibility With the Addition of YuJa Panorama Digital Accessibility Platform to Its Ed • Discover Savings and Serenity at Holy Name's Open House - May 4 & 5 • Strategic Education, Inc. Reports First Quarter 2024 Results • Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada • BrightFocus Foundation Announces $10M in New Funding Across Brain and Vision Research, Celebrates Historic Diversity of Grant Aw • Wounded Warrior Project, White House Celebrate and Honor Warriors at Annual Soldier Ride • Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business • CUPE BC, province’s largest union, kicks off convention in Vancouver • PONIX AWARDED $5 MILLION USDA GRANT TO BREAK "GROUND" ON CLIMATE-SMART AGRICULTURE IN GEORGIA • God's Mighty Hand Can Uphold His Children Even Through The Hardest Times • ERVIN COHEN & JESSUP PARTNER RECOGNIZED AS TOP LAWYER IN LOS ANGELES • Voices for Humanity Bears Witness to Panama's Moral Resurgence With Giselle Lima • NICOLE ARI PARKER IS THE FACE OF KAREN MILLEN'S ICONS SERIES VOL. 6

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

NEW BRUNSWICK, N.J. , June 06 /Businesswire/ - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Thursday, July 20^th to review second-quarter results. Joaquin Duato, Chairman of the Board and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call.

Investors and other interested parties can access the webcast/conference call in the following ways:

The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
A replay of the conference call will be available until approximately 12:00 a.m. on August 2^nd. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13739164.
The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the third-quarter date of Tuesday, October 17^th, 2023.

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest, most diversified healthcare products company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.